Potential Pre-Leukemic Mutations in PPM1D Confer Chemotherapy Resistance to Aged HSC Clones
Main Author: | Michael D. Milsom |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-02-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000171 |
Similar Items
-
EGR1 dysregulation defines an inflammatory and leukemic program in cell trajectory of human-aged hematopoietic stem cells (HSC)
by: Christophe Desterke, et al.
Published: (2021-07-01) -
Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
by: Borahm Kim, et al.
Published: (2019-01-01) -
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
by: Nathan R. Fons, et al.
Published: (2019-08-01) -
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
by: Terrence N. Wong, et al.
Published: (2018-01-01) -
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
by: G Wei Xu, et al.
Published: (2014-01-01)